Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label, Randomized, Controlled Phase III Clinical Study of the Efficacy and Safety of Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma

NCT02082522 is registered in ClinicalTrials.gov with Concordia Laboratories Inc. as lead sponsor.

NCT NCT02082522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02082522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label, Randomized, Controlled Phase III Clinical Study of the Efficacy and Safety of Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Unresectable Advanced Perihilar Cholangiocarcinoma
Lead sponsor
Concordia Laboratories Inc.
Phase
Phase 3
Overall status
Terminated
Start date
November 12, 2014
Completion date
January 12, 2017
Enrollment
28 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hilar cholangiocarcinoma